Kalijev Klorid Belupo (Potassium Chloride)

After oral ingestion, potassium chloride dissociates into potassium and chloride ions. The potassium ions are absorbed into the bloodstream, raising serum potassium concentration and restoring normal cellular electrical activity. This supports proper nerve transmission, muscle contraction, and heart rhythm.

The dose of Kalijev Klorid Belupo is individualized by the prescribing clinician based on the patient’s serum potassium level, underlying condition, renal function, and concurrent medications. Only a qualified health professional should set the dosage and monitoring schedule.

Safety data for potassium chloride in pregnancy and lactation are limited. It should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kalijev Klorid Belupo provides potassium chloride, the most common oral potassium salt. Compared with potassium gluconate or potassium citrate, it delivers a higher elemental potassium per dose, making it suitable for rapid correction of significant deficits, while the safety profile remains similar across salts.

Store Kalijev Klorid Belupo at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture, excessive heat and direct sunlight to maintain stability and potency.

Kalijev Klorid Belupo is taken orally, usually with a full glass of water. It may be administered with or without food, depending on the prescriber’s advice, and the patient should follow the specific instructions provided on the label or by their healthcare professional.

The most serious risk is hyperkalemia, an excessively high serum potassium level, which can lead to cardiac arrhythmias, muscle weakness, or even cardiac arrest. Prompt monitoring of potassium levels and awareness of drug interactions are essential to mitigate this risk.

Patients with known hyperkalemia, severe renal impairment, or those taking other potassium‑raising agents (such as ACE inhibitors, ARBs, or potassium‑sparing diuretics) without close monitoring should avoid using Kalijev Klorid Belupo unless a physician determines it is safe.